Herbal Formula Science (대한한의학방제학회지)

The Korean Medicine Society for the Herbal Formula Study (대한한의학방제학회)
권호 표지
DOI QR코드

DOI QR Code

An analysis of Clinical Studies on Oryeong-San

오령산에 대한 임상연구 분석

  • Seok, Eun-Joo (Department of Herbal Formula Science, College of Korean Medicine, Dongshin University) ;
  • Jeon, Su-Yeon (Department of Herbal Formula Science, College of Korean Medicine, Dongshin University) ;
  • Kim, Won-Bae (Department of Herbal Formula Science, College of Korean Medicine, Dongshin University) ;
  • Kim, Do-Hyun (Department of Herbal Formula Science, College of Korean Medicine, Dongshin University) ;
  • Lee, Soong-In (Department of Herbal Formula Science, College of Korean Medicine, Dongshin University)
  • 석은주 (동신대학교 한의과대학 방제학교실) ;
  • 전수연 (동신대학교 한의과대학 방제학교실) ;
  • 김원배 (동신대학교 한의과대학 방제학교실) ;
  • 김도현 (동신대학교 한의과대학 방제학교실) ;
  • 이숭인 (동신대학교 한의과대학 방제학교실)
  • Received : 2018.09.27
  • Accepted : 2018.11.02
  • Published : 2018.11.30
Download PDF
⟨ Previous Next ⟩

Abstract

Objective : This study's purpose was to review the clinical studies of Oryeong-San. Method : We searched papers about Oryeong-San using KISS, KTKP, PUBMED, Embase, Science Direct, and the key words "Goreisan", "Goreito", "Wu Ling San", "Oryeongsan", "Poria Five Powder" were used. Papers not matched with inclusion criteria were excluded. Results : Until today, there have been 133 studies on the effects of head diseases, urinary system diseases, edema, and other various effects of Oryeong-San. Of these, 23 studies were classified as clinical research papers. There were 8 cases of head diseases, 5 cases of urinary system diseases, 3 cases of edema, 2 cases of adjuvant, 1 case of Dysmenorrhea, 1 case of Primary Hypertension, 1 case of Primary Insomnia, 1 case of hydrocele, 1 case of side effects causing TINU syndrome. Conclusion : It can be seen that Oryeong-San has established the basis for application to the purpose of head disease(chronic subdural hematoma, hydrocephalus, hearing loss), urinary system disease(stone, urinary tract infection), edema, adjuvant, other hypertension and insomnia. On the other hand, considering one case that causes side effect of TINU syndrome, caution should be exercised when observing the progress of the patient taking the Oryeong-San.

Keywords

HBBJBB_2018_v26n4_341_f0001.png 이미지

Figure. 1. Flow chart of the trial selection process and classification.

Table1. The clinical studies of ORS

HBBJBB_2018_v26n4_341_t0001.png 이미지

Table2. The clinical studies of ORS used for Head diseases

HBBJBB_2018_v26n4_341_t0002.png 이미지

Table3. The clinical studies of ORS used for Urinary system diseases

HBBJBB_2018_v26n4_341_t0003.png 이미지

Table4. The clinical studies of ORS used for Edema

HBBJBB_2018_v26n4_341_t0004.png 이미지

Table5. The clinical studies of ORS used for Adjuvant

HBBJBB_2018_v26n4_341_t0005.png 이미지

Table6. The clinical studies of ORS used for Others

HBBJBB_2018_v26n4_341_t0006.png 이미지

References

  1. Moon JJ, Ahn GS, Kim SH, Park JH, Kim DH, Choi DY, et al. ShangHanLunJeongHae. Seoul:Publicaton HanEuiMunHwaSa. 2010: 176-82, 329.
  2. Lee SI, Cho HR. The Comparisons of Shanghanlun. Korean Medical Association of clinical Sanghan-Geumgwe. 2015:203
  3. Kook YB, Kim SC, Park SD, Park SK, Seo BI, Seo YB, Shin SS, Lee SI, Lee JC, Lee KH, Jeong JG, Ju YS, Choi HY. Formula Study. Seoul:Younglimsa. 2006:504-5.
  4. Otsuka K. Explanation in Symptomatical Practice of Kampo-Medicine. Wonju:Euibangseolim. 2013:27, 34, 69.
  5. The society of Korean Medicine. EvidenceBased of Korean Medicine Treatment. Seoul. Publicaton Gunja. 2011:2.
  6. The Japan Society for Oriental Medicine EBM Special Committee. Herbal Formula of EvidenceBased. Seoul. Korea Medical Book. 2004.
  7. Kim JH, Shin HG. Analysis of biological experiment on Oryeong-san (Wuling-san). Journal of korean oriental internal medicine. 2012;33(1):69-82.
  8. Park HY, Hwang YH, Ha JH, Jeong GY, Ma JY. Acute Toxicity Study on Oryeong-san in Mice. Journal of korean oriental herbal formula study. 2013;21(1):111-18. https://doi.org/10.14374/HFS.2013.21.1.111
  9. Bang JG. A Study on Syndromes of Oryeongsan. Journal of Oriental Medical Classics. 2007; 20(1):151-64.
  10. Kim HY, Ryu HY. A Literature Review on the Internal Medicine of Oryeongsan. Journal of korean oriental internal medicine. 1993;14(2):79-91.
  11. Jeong MJ, Gang GY, Gang JY, Yun JH, Choe YM, Kim HJ, Seon SH, Jang YS. An Overview of the Applicability of Oryung-san as an Antihypertensive Agent. Journal of korean oriental internal medicine. 2017; 38(4):443-54. https://doi.org/10.22246/jikm.2017.38.4.443
  12. Lee HY, Gang GY, Lee E, Lee SH, Han CH, Jang IS. A Systematic Review on Antihypertensive Effects of Oryeong-san. Journal of korean oriental internal medicine. 2013;34(3):289-97.
  13. David AG, Kenneth FS. an overview of clinical research:the lay of the land. The Lancet. 2002;359(9300):57-61. https://doi.org/10.1016/S0140-6736(02)07283-5
  14. Miyagami M, Kagawa Y. Effectiveness of Kampo medicine Gorei-San for chronic subdural hematoma. No Shinkei Geka. Neurological Surgery. 2009;37(8):765-70.
  15. Wakabayashi Y, Yamashita M, Asano T, Yamada A, Kenai H, Kondoh Y, Hori Y, Nagatomi H. Effect of Gorei-san with tranexamic acid for preventing recurrence of chronic subdural hematoma. No Shinkei Geka. Neurological Surgery. 2012;40(11):967-71.
  16. Okamura A, Kawamoto Y, Sakoda E, Murakami T, Hara T. Evaluation of recurrence factors and Gorei-san administration for chronic subdural hematoma after percutaneous subdural tapping. Hiroshima J Med Sci. 2013;62(4):77-82.
  17. Yasunaga H. Effect of Japanese Herbal Kampo Medicine Goreisan on Reoperation Rates after Burr-Hole Surgery for Chronic Subdural Hematoma:Analysis of a National Inpatient Database. Evid Based Complement Alternat Med. 2015;2015.
  18. Cho KH, Kwon S, Jung WS, Moon SK. Herbal Medicine, Oreongsan for Recurrent Chronic Subdural Hematoma:A Case Report. Explore: The Journal Of Science &Healing. 2017;13(2):139-41 https://doi.org/10.1016/j.explore.2016.12.008
  19. Jeong YG, Kim SB, Yang JY, Mun SG, Jeong YS, Gwon SW, Jo GH. Two Case Studies of the Use of Oreong-san for a Chronic Subdural Hematoma. Journal of korean oriental internal medicine. 2017;38(3):259-63. https://doi.org/10.22246/jikm.2017.38.2.259
  20. Go HY, Jeong SM, Im YM, Park JS, Jeon CY. A Case Report of Normal Pressure Hydrocephalus. Journal of korean oriental internal medicine. 2004;25(4):221-6.
  21. Okada K, Ishimoto S, Fujimaki Y, Yamasoba T. Trial of Chinese medicine Wu-Ling-San for acute low-tone hearing loss. ORL J Otorhinolaryngol Relat Spec. 2012;74(3):158-63. https://doi.org/10.1159/000337819
  22. Yoshimura K, Miyake O, Okuyama A, Yoshioka T, Honda M, Yamaguchi S, Koide T. Effect of chorei-to and gorei-san on calcium oxalate crystallization in human urine. Hinyokika Kiyo. 1998;44(1):13-6.
  23. Lin E, Ho L, Lin MS, Huang MH, Chen WC. Wu-Ling-San formula prophylaxis against recurrent calcium oxalate nephrolithiasis - a prospective randomized controlled trial. fr J Tradit Complement Altern Med. 2013;10(5):199-209.
  24. Wu SY, Chen HY, Tsai KS, Chiang JH, Muo CH, Sung FC, Chen YH, Chen WC. Long-Term Therapy With Wu-Ling-San, a Popular Antilithic Chinese Herbal Formula, Did Not Prevent Subsequent Stone Surgery: A Nationwide Population-Based Cohort Study. Inquiry. 2016;53.
  25. Jeong EH, Yu JE, Choe GH, Yu DY. Four Cases Report of the Female Lower Urinary Tract Infection with Oryeong-san. The Journal Of Oriental Gynecology. 2012;25(4):134-43.
  26. Lin SK, Lin PH, Hsu RJ, Chuang HC, Liu JM. Traditional Chinese medicine therapy reduces the catheter indwelling risk in dementia patients with difficult voiding symptoms. J Ethnopharmacol. 2017;203:120-6. https://doi.org/10.1016/j.jep.2017.03.040
  27. Makimoto F, Akiyama J, Sato K, Watanabe K, Ushiroyama T. Amniotic pocket changes following Wu-Ling-San treatment for gestational edema. Am J Chin Med. 2013;41(2):293-9. https://doi.org/10.1142/S0192415X13500213
  28. Lee JY, Chae J, Jeong UH, Lee SG, Jeong HS. Two Cases of Cancer-induced Lymphedema Patients Treated with Oryeongsan. Journal of korean oriental internal medicine. 2013; 34(3):322-28.
  29. Komiyama S, Takeya C, Takahashi R, Yamamoto Y, Kubushiro K. Feasibility study on the effectiveness of Goreisan-based Kampo therapy for lower abdominal lymphedema after retroperitoneal lymphadenectomy via extraperitoneal approach. J Obstet Gynaecol Res. 2015;41(9):1449-56. https://doi.org/10.1111/jog.12721
  30. Yamada K, Yagi G, Kanba S. Effectiveness of Gorei-san (TJ-17) for treatment of SSRI-induced nausea and dyspepsia:preliminary observations. Clin Neuropharmacol. 2003; 26(3):112-4. https://doi.org/10.1097/00002826-200305000-00002
  31. Kori K, Oikawa T, Odaguchi H, Omoto H, Hanawa T, Minami T. Go-rei-San, a Kampo medicine, reduces postoperative nausea and vomiting:a prospective, single-blind, randomized trial. J Altern Complement Med. 2013; 19(12):946-50. https://doi.org/10.1089/acm.2013.0118
  32. Heo J. A Case Report of Dysmenorrhea treated by Oryeong-san based on Shanghanlun provisions. Korean Medical Association of Clinical Sanghan-Geumgwe. 2014;6(1):63-70.
  33. Jang IS, Kim MJ, Han HJ, Jeong MJ, Gang SY. Treatment of Primary Hypertension by Oryung-san Monotherapy:a Case Report. 2014;35(1):106-10
  34. Park JG. A Case Report of Primary Insomnia treated by Oryeong-san decoction. Korean Medical Association of Clinical Sanghan-Geumgwe. 2015;7(1):45-52.
  35. Takeda N, Tanaka K, Watanabe E, Kakihara T, Watanabe M, Kawahara H. Efficacy of the traditional Japanese medicine goreisan for the resolution of spermatic cord hydrocele in children. Surg Today. 2017;48(3):175-9.
  36. Suzuki H, Yoshioka K, Miyano M, Maeda I, Yamagami K, Morikawa T, Okada N, Konishi Y, Imanishi M. Tubulointerstitial nephritis and uveitis (TINU) syndrome caused by the Chinese herb "Goreisan". Clin Exp Nephrol. 2009;13(1):73-6. https://doi.org/10.1007/s10157-008-0069-y
  37. Sahyouni R, Goshtasbi K, Mahmoodi A, Tran DK, Chen JW. Chronic Subdural Hematoma: A Historical and Clinical Perspective. World Neurosurgery. 2017;108:948-53. https://doi.org/10.1016/j.wneu.2017.09.064
  38. Adams RD, Fisher CM, Hakim S, Ojemann RG, Sweet WH. Symptomatic occult hydrocephalus with "normal' cerebrospinal pressure:A treatable syndrome. New England journal of medicine. 1965;273:117-49 https://doi.org/10.1056/NEJM196507152730301
  39. Nassar BR, Lippa CF. Idiopathic Normal Pressure Hydrocephalus:A Review for General Practitioners. Gerontology & Geriatric Medicine. 2016:2:1-6.
  40. Roh KJ, Lee EJ, Park AY, Choi BI, Son EJ. Long-Term Outcomes of Acute Low-Tone Hearing Loss. Journal of Audiology and Otology. 2015;19(2):74-8. https://doi.org/10.7874/jao.2015.19.2.74
  41. Bullock N, Doble A, Turner W, Cuckow P. Urology - An Illustrated Color Text. Publicaton Gunja. 2010:54-9.
  42. Fauci A, Braunwald E, Kasper D, Hauser S, Longo D, Jameson J, Loscalzo J. Harrison's Internal Medicine. Seoul:MIP. 2010:2195-6.
  43. Korean Society of Obstetrics and Gynecology. Obstetrics. Publicaton Gunja. 2007:773,811,816.
  44. The Korean Society of Lymphedema. Lymphedema. Publicaton Gunja. 2012:34, 37-8, 49.
  45. Katzung BG, Masters SB, Trevor AJ. Basic and Clinical Pharmacology. Seoul:Beommuneducation. 2014:535, 547.
  46. Lee HY, Kang1KW, Lee E, Lee SH, Han CH, Jang IS. A Systematic Review on Antihypertensive Effects of Oryeong-san. Korean J. Orient. Int. Med. 2013;34(3):289-97.
  47. Jeong MJ, Kang KW, Kang JY, Yoon JH, Choi YM, Kim HJ, Sun SH, Jang IS. An Overview of the Applicability of Oryung-san as an Antihypertensive Agent. J. Int. Korean Med. 2017;38(4):443-54. https://doi.org/10.22246/jikm.2017.38.4.443
  48. An HS. Hong Chang's Pediatrics. Seoul:MiRaeaen. 2012:922.
  49. Chang YT, Lee JY, Wang JY, Chiou CS, Chang CC. Hydrocele of the spermatic cord in infants and children:its particular characteristics. Urology. 2010;76(1):82-6. https://doi.org/10.1016/j.urology.2010.02.062
  50. Linda OO, Peter H, Philip IM, Alastair KD. Tubulointerstitial nephritis and uveitis (TINU) syndrome:a systematic review of its epidemiology, demographics and risk factors. Orphanet Journal of Rare Diseases. 2017;12:128. https://doi.org/10.1186/s13023-017-0677-2
  51. "oryeongsan." OASIS Oriental Medicine Advanced Searching Integrated System. https://oasis.kiom.re.kr/oasis/pres/prdetailView5.jsp?idx=15&selectname=null&srch_menu_nix=null(last modified Aug 6, 2018, accessed Aug 10, 2018.)